Catalyst Wire Dossier Catalyst Wire Dossier

GemOx (gemcitabine + oxaliplatin)

gemcitabine and oxaliplatin
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GemOx (gemcitabine + oxaliplatin), covering 2019-05-21 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma [Phase 2]

See pricing